ワクチンの発見と,新しいワクチン技術の翻訳
Rino Rappuoli1, Steven Black, Paul Henri Lambert
1Novartis Vaccines, Siena, Italy. rino.rappuoli@novartis.com
Lancet (London, England)
|June 14, 2011
まとめ
ワクチンの開発における最近の進歩は,より広範な病気に対するより効果的なワクチンを導きました. 新しい技術は,様々な病気に対する将来のワクチンを約束し,公衆の健康と安全を改善します.
科学分野:
- ワクチン学 ワクチン学
- 免疫学 免疫学とは
- バイオテクノロジー バイオテクノロジー
背景:
- 過去30年間,ワクチンの開発に大きな進展がありました.
- 新しいワクチンは,より広範な保護,より少ない注射,および強化された安全性プロファイルを提供します.
研究 の 目的:
- ワクチンの開発における最近の進展をレビューし,将来の方向性を探求する.
- 新種の発見方法とそのワクチン設計への潜在的影響を強調する.
主な方法:
- 逆ワクチン学,構造生物学,システム生物学を含む新しいワクチン発見技術のレビュー.
- 新興ワクチン安全性評価技術の検討.
主要な成果:
- 感染性疾患の幅広い範囲に対するワクチン開発.
- 安全性,純度,投与スケジュールを改善したワクチンの導入.
- 新種のワクチンの出現は,自己免疫疾患や癌を含む感染症以外の標的を対象としています.
結論:
- 将来のワクチンの開発は,革新的な発見と安全性評価のツールを活用して,多様な集団と病気をターゲットにします.
- 実施の成功には,製造業者,規制当局,公衆衛生プログラム間の協力が求められ,迅速な利用可能性と公衆の信頼を確保します.
関連する概念動画
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Initiation of Translation
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Vaccinations
Overview

